| Title |
|
|
|
Immune cells enhance selectivity of nanosecond-pulsed DBD plasma against tumor cells
|
|
| Author |
|
|
|
|
|
| Abstract |
|
|
|
| Cancer immunotherapy is a promising strategy that engages the patient's immune system to kill cancer cells selectively while sparing normal tissue. Treatment of macrophages with a nanosecond-pulsed dielectric barrier discharge directly enhanced their cytotoxic activity against tumor cells but not normal cells. These results underscore the clinical potential of plasma for cancer immunotherapy. |
|
|
| Language |
|
|
|
English
|
|
| Source (journal) |
|
|
|
Plasma medicine |
|
| Publication |
|
|
|
2017
|
|
| Volume/pages |
|
|
|
7:1(2017), p. 85-96
|
|
| Full text (Publisher's DOI) |
|
|
| |
|
| Full text (publisher's version - intranet only) |
|
|
| |
|